Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series

AUTOR(ES)

Aguilar, Ana C.

FONTE

Braz. J. Psychiatry

DATA DE PUBLICAÇÃO

20/12/2019

RESUMO

Objective: To report the successful use of lisdexamfetamine in the management of narcolepsy. Methods: Five narcoleptic patients received lisdexamfetamine, at different dosages and for different periods, for management of excessive daytime sleepiness and weight control. Results: All patients experienced improvement of excessive daytime sleepiness and lost weight without side effects. Conclusion: Lisdexamfetamine appears promising for the treatment of two of the most common symptoms of narcolepsy: excessive daytime sleepiness and weight gain.

Documentos Relacionados

• Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series
• Narcolepsy and excessive daytime sleepiness
• EXCESSIVE DAYTIME SLEEPINESS AND HEALTH DAMAGE IN NURSING CLINIC SURGICAL WORKERS
• Interaction between apolipoprotein E genotypes, excessive daytime sleepiness, and cognitive function in obstructive sleep apnea patients
• SUBJECTIVE SLEEP NEED AND DAYTIME SLEEPINESS IN ADOLESCENTS